- Home
- KNOP vs CATX Comparison
KNOP vs CATX Comparison
Compare KNOP & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- CATX
- Stock Information
- Founded
- KNOP 2013
- CATX 1983
- Country
- KNOP United Kingdom
- CATX United States
- Employees
- KNOP N/A
- CATX N/A
- Industry
- KNOP Marine Transportation
- CATX Medical/Dental Instruments
- Sector
- KNOP Consumer Discretionary
- CATX Health Care
- Exchange
- KNOP Nasdaq
- CATX Nasdaq
- Market Cap
- KNOP 199.5M
- CATX 183.2M
- IPO Year
- KNOP 2013
- CATX N/A
- Fundamental
- Price
- KNOP $6.93
- CATX $2.14
- Analyst Decision
- KNOP
- CATX Strong Buy
- Analyst Count
- KNOP 0
- CATX 11
- Target Price
- KNOP N/A
- CATX $15.30
- AVG Volume (30 Days)
- KNOP 72.6K
- CATX 562.0K
- Earning Date
- KNOP 03-19-2025
- CATX 03-26-2025
- Dividend Yield
- KNOP 1.51%
- CATX N/A
- EPS Growth
- KNOP N/A
- CATX N/A
- EPS
- KNOP 0.18
- CATX N/A
- Revenue
- KNOP $312,629,000.00
- CATX $1,454,000.00
- Revenue This Year
- KNOP $1.40
- CATX N/A
- Revenue Next Year
- KNOP $2.53
- CATX $1.15
- P/E Ratio
- KNOP $36.02
- CATX N/A
- Revenue Growth
- KNOP 8.60
- CATX 1.40
- 52 Week Low
- KNOP $4.94
- CATX $2.01
- 52 Week High
- KNOP $9.11
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- KNOP 74.66
- CATX 31.85
- Support Level
- KNOP $6.53
- CATX $2.32
- Resistance Level
- KNOP $6.84
- CATX $2.62
- Average True Range (ATR)
- KNOP 0.22
- CATX 0.19
- MACD
- KNOP 0.13
- CATX -0.01
- Stochastic Oscillator
- KNOP 98.42
- CATX 16.25
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.